| Title | Author(s) | Year | View Count |
 | Identification of molecular determinants for efficient H5pp production | Lam, YM; Tang, D; Chu, SL; Nal-Rogier, BTM; Bruzzone, R; Lam, CHP | 2010 | 76 |
 | Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro | Kam, YW; Kien, F; Roberts, A; Cheung, YC; Lamirande, EW; Vogel, L; Chu, SL; Tse, J; Guarner, J; Zaki, SR; Subbarao, K; Peiris, M; Nal, B; Altmeyer, R | 2007 | 313 |
| H5 pseudotyped lentiviral particles: a new tool for sero-diagnosis of influenza H5N1 infection | Garcia, J; Nefkens, I; Lagarde, NJC; Chu, SL; Buchy, P; Altmeyer, RM; Peiris, JSM | 2007 | 98 |
| FcgammaRII-mediated SARS-CoV entry in human B cell lines | Jaume, MDA; Kien, FS; Kam, YW; Corby, P; Li, PH; Chu, SL; Tse, KS; CHEUNG, YC; Peiris, JSM; Daeron, M; Nal-Rogier, BTM; Altmeyer, RM | 2006 | 94 |
| Immunization with trimeric S glycoprotein protects from SARS-CoV challenge despite the presence of in vitro facilitating antibodies | Kam, YW; Kien, FS; Roberts, A; Cheung, CY; Lamirande, E W; Vogel, L; Chu, SL; Chan, CM; Tse, KS; Subarao, K; Peiris, JSM; Nal-Rogier, BTM; Altmeyer, RM | 2005 | 110 |
| Immunization with trimeric S glycoprotein protects from SARS-CoV challenge despite the presence of in vitro facilitating antibodies | Kien, FS; Kam, YW; Roberts, A; Cheung, CY; Lamirande, E W; Vogel, L; Chu, SL; Chan, CM; Tse, KS; Subbarao, K; Peiris, JSM; Nal-Rogier, BTM; Altmeyer, RM | 2005 | 112 |
| Phase Transformation Behaviour of Porous NiTi Alloys Fabricated by Capsule-Free Hot Isostatic Pressing | Wu, SL; Liu, XM; Chu, PK; Chung, CY; Chu, SL; Yeung, KWK | 2005 | 70 |
| Biogenesis and subcellular localization of the SARS coronavirus surface proteins | Nal-Rogier, BTM; Chan, CM; Siu, YL; Chu, SL; Altmeyer, RM | 2004 | 151 |
|
